Off-the-Shelf immune cell therapy tested for tough blood cancers
Disease control
Recruiting now
This study is testing a new type of cell therapy called WU-CART-007 for people with T-cell leukemia or lymphoma that has come back or hasn't responded to other treatments. The therapy uses donor immune cells engineered to attack cancer cells. The main goal is to see if it can put…
Phase: PHASE2 • Sponsor: Wugen, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC